The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
Abstract
Adiponectin is an adipocyte-derived hormone. Recent genome-wide scans have mapped a susceptibility locus for type 2 diabetes and metabolic syndrome to chromosome 3q27, where the gene encoding adiponectin is located. Here we show that decreased expression of adiponectin correlates with insulin resistance in mouse models of altered insulin sensitivity. Adiponectin decreases insulin resistance by decreasing triglyceride content in muscle and liver in obese mice. This effect results from increased expression of molecules involved in both fatty-acid combustion and energy dissipation in muscle. Moreover, insulin resistance in lipoatrophic mice was completely reversed by the combination of physiological doses of adiponectin and leptin, but only partially by either adiponectin or leptin alone. We conclude that decreased adiponectin is implicated in the development of insulin resistance in mouse models of both obesity and lipoatrophy. These data also indicate that the replenishment of adiponectin might provide a novel treatment modality for insulin resistance and type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increases in adiponectin have been demonstrated to improve insulin sensitivity through insulin-sensitizing effects in mice [20].”
From Tirzepatide as monotherapy improved markers of beta-cell function and insulin sensitivity in type 2 diabetes (SURPASS-1). (2023) · cites this paper as [20]
In the citing paper
“Adiponectin is exclusively produced in adipocytes, and adiponectin levels are lower in T2D and obesity compared to the healthy state [20, 21].”
From Tirzepatide as monotherapy improved markers of beta-cell function and insulin sensitivity in type 2 diabetes (SURPASS-1). (2023) · cites this paper as [20]
In the citing paper
“(v) in rodents, injection of recombinant adiponectin increases fat oxidation, reduces intamyocellular lipid, and improves insulin sensitivity [77];”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [77]
In the citing paper
“High-fat diet-induced obesity leads to reduced expression of ApN, thereby causing insulin resistance [47].”
From Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together? (2020) · cites this paper as [47]
In the citing paper
“Administration of ApN lowered blood sugar and reduced insulin resistance in mice under a high-fat diet (HFD) [47].”
From Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together? (2020) · cites this paper as [47]
In the citing paper
“Adiponectin administration decreases IHTG (35), increases hepatic insulin sensitivity (36), and reverses obesity-related skeletal muscle insulin resistance (37).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [37]
In the citing paper
“It is thought that adiponectin can decrease the insulin resistance of obesity (28–30).”
From Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults (2004) · cites this paper as [30]
In the citing paper
“Likewise, in one animal model, leptin alone produced a near-maximal effect (35), whereas a second model demonstrated a synergistic effect with adiponectin (33).”
From Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy (2005) · cites this paper as [33]
In the citing paper
“Adiponectin is another adipokine that is associated with increased insulin sensitivity and fatty acid oxidation (33).”
From Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy (2005) · cites this paper as [33]
Citations
Cites
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,261
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,081
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.2005 · Cited by 2,007
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomázy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,815
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,730
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–236 of 236
Moran, L. J., Noakes, M., Clifton, P. M., Wittert, G. A., Belobrajdic, D. P., & Norman, R. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2336 · Cited by 66
Adiponectin as a tissue regenerating hormone: More than a metabolic function
Fiaschi, T., Magherini, F., Gamberi, T., Modesti, P. A., & Modesti, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1537-4 · Cited by 66
You, Y., Han, X., Guo, J., Guo, Y., Yin, M., Liu, G., Huang, W., & Zhan, J. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2017.12.025 · Cited by 65
Ueno, H., Koyama, H., Shoji, T., Monden, M., Fukumoto, S., Tanaka, S., Otsuka, Y., Mima, Y., Morioka, T., Mori, K., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.04.006 · Cited by 65
Cong, L., Chen, K., Li, J., Gao, P., Li, Q., Mi, S., Wu, X., & Zhao, A. Z. (2007) · Biochemical Journal · doi:10.1042/bj20061478 · Cited by 62
Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study
Patel, D. A., Srinivasan, S. R., Xu, J.-H., Chen, W., & Berenson, G. S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.06.028 · Cited by 62
Pathways leading to muscle insulin resistance – The muscle – fat connection
Sell, H., Eckel, J., & Dietze-Schroeder, D. (2006) · Archives of Physiology and Biochemistry · doi:10.1080/13813450600711540 · Cited by 61
Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity
Okada-Iwabu, M., Iwabu, M., Ueki, K., Yamauchi, T., & Kadowaki, T. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.5.363 · Cited by 60
Gu, W., Li, X., Liu, C., Yang, J., Ye, L., Tang, J., Gu, Y., Yang, Y., Hong, J., Zhang, Y., et al. (2006) · Endocrine · doi:10.1385/endo:30:2:217 · Cited by 58
Low Circulating Adiponectin Levels in Women with Polycystic Ovary Syndrome: An Updated Meta-Analysis
Li, S., Huang, X., Zhong, H., Peng, Q., Chen, S., Xie, Y., Qin, X., & Qin, A. (2014) · Tumor Biology · doi:10.1007/s13277-013-1595-0 · Cited by 58
Ohlsson, C., Hammarstedt, A., Vandenput, L., Saarinen, N., Ryberg, H., Windahl, S. H., Farman, H. H., Jansson, J.-O., Movérare-Skrtic, S., Smith, U., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00093.2017 · Cited by 55
Delporte, M.-L., El Mkadem, S. A., Quisquater, M., & Brichard, S. M. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00488.2003 · Cited by 55
Lipoatrophy and metabolic disturbance in mice with adipose-specific deletion of kindlin-2
Gao, H., Guo, Y., Yan, Q., Yang, W., Li, R., Lin, S., Bai, X., Liu, C., Chen, D., Cao, H., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128405 · Cited by 53
Adiponectin signaling and its role in bone metabolism
Pal China, S., Sanyal, S., & Chattopadhyay, N. (2018) · Cytokine · doi:10.1016/j.cyto.2018.06.012 · Cited by 53
Watanabe, T., Kubota, N., Ohsugi, M., Kubota, T., Takamoto, I., Iwabu, M., Awazawa, M., Katsuyama, H., Hasegawa, C., Tokuyama, K., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807120200 · Cited by 53
Self-citationThe roles of leptin and adiponectin at the fetal-maternal interface in humans
Dos Santos, E., Duval, F., Vialard, F., & Dieudonné, M.-N. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0031 · Cited by 52
Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1
Park, S.-Y., Cho, Y.-R., Kim, H.-J., Hong, E.-G., Higashimori, T., Lee, S. J., Goldberg, I. J., Shulman, G. I., Najjar, S. M., & Kim, J. K. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00077.2006 · Cited by 51
Si, Y., Palani, S., Jayaraman, A., & Lee, K. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600343-jlr200 · Cited by 50
Lee, C. J., Mao, H., Thieu, V. T., Landó, L. F., & Thomas, M. K. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad056 · Cited by 47
“Adiponectin is exclusively produced in adipocytes, and adiponectin levels are lower in T2D and obesity compared to the healthy state [20, 21].”
Effects of sleep restriction on adiponectin levels in healthy men and women
Simpson, N. S., Banks, S., Arroyo, S., & Dinges, D. F. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.08.006 · Cited by 46
(2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.012 · Cited by 46
Adiponectin and HIV-Lipodystrophy: Taking HAART
Kinlaw, W. B., & Marsh, B. (2004) · Endocrinology · doi:10.1210/en.2003-1513 · Cited by 44
Singh, A. K., Joharapurkar, A. A., Khan, M. P., Mishra, J. S., Singh, N., Yadav, M., Hossain, Z., Khan, K., Kumar, S., Dhanesha, N. A., et al. (2014) · Diabetes · doi:10.2337/db13-1619 · Cited by 43
Androgens, Obesity, and Sleep-Disordered Breathing in Men
Liu, P. Y., Caterson, I. D., Grunstein, R. R., & Handelsman, D. J. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.03.002 · Cited by 43
Adipokines in healthy skeletal muscle and metabolic disease
Coles, C. A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-27511-6_6 · Cited by 39
Globular Adiponectin Activates Motility and Regenerative Traits of Muscle Satellite Cells
Fiaschi, T., Giannoni, E., Taddei, M. L., & Chiarugi, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034782 · Cited by 37
Fiaschi, T., Tedesco, F. S., Giannoni, E., Diaz-Manera, J., Parri, M., Cossu, G., & Chiarugi, P. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-04-0310 · Cited by 35
Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice
Wang, Y., Wan, Y., Ye, G., Wang, P., Xue, X., Wu, G., & Ye, B. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.08.017 · Cited by 34
Takahashi, T., Saegusa, S., Sumino, H., Nakahashi, T., Iwai, K., Morimoto, S., & Kanda, T. (2005) · Journal of International Medical Research · doi:10.1177/147323000503300208 · Cited by 33
Hong, K., Lee, S., Li, R., Yang, Y., Tanner, M. A., Wu, J., & Hill, M. A. (2016) · Microcirculation · doi:10.1111/micc.12266 · Cited by 30
Lipocalin 13 regulation of glucose and lipid metabolism in obesity
Zhou, Y., & Rui, L. (2013) · Vitamins & Hormones · doi:10.1016/b978-0-12-407766-9.00015-8 · Cited by 28
Aberdein, N., Dambrino, R. J., do Carmo, J. M., Wang, Z., Mitchell, L. E., Drummond, H. A., & Hall, J. E. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00287.2017 · Cited by 21
Sex-steroid milieu determines diabetes rescue in pttg-null mice
Fraenkel, M., Caloyeras, J., Ren, S.-G., & Melmed, S. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06656 · Cited by 20
Onaolapo, A. Y., Adebisi, E. O., Adeleye, A. E., Olofinnade, A. T., & Onaolapo, O. J. (2020) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666191009161228 · Cited by 20
Obesity and Exercise: New Insights and Perspectives
James, N. M., & Stanford, K. I. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf017 · Cited by 20
Nishida, Y., Higaki, Y., Taguchi, N., Hara, M., Nakamura, K., Nanri, H., Imaizumi, T., Sakamoto, T., Shimanoe, C., Horita, M., et al. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00255 · Cited by 17
Metadata
- Authors
- Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M. L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P., & Kadowaki, T.
- Affiliations
- The University of Tokyo (JP)
- Centre National de la Recherche Scientifique (FR)
- National Institute of Health and Nutrition (JP)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- National Institutes of Health (US)
- SHOWA Medical University (JP)
- Corresponding author
- Kadowaki, T.
- ORCID
- Venue
- Nature Medicine
- Published
- 2001-08
- Volume
- 7
- Issue
- 8
- Pages
- 941-946
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1587875569
- Cited by
- 4,915
- References
- 38
- Citations by year
- 2026: 48 · 2025: 75 · 2024: 100 · 2023: 127 · 2022: 125 · 2021: 127 · 2020: 214 · 2019: 168 · 2018: 152 · 2017: 157 · 2016: 203 · 2015: 208 · 2014: 198 · 2013: 258 · 2012: 229
- FWCI
- 160.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- adiponectin, insulin resistance, lipoatrophy, obesity, type 2 diabetes, leptin, triglyceride content, muscle, liver, fatty acid oxidation, energy dissipation, chromosome 3q27, metabolic syndrome, adipokines
- MeSH terms
- Adipose Tissue, Amino Acid Sequence, Animals, Insulin Resistance, Molecular Sequence Data, Obesity, Oxidation-Reduction, Proteins, Transcription Factors, Triglycerides, Signal Transduction, Receptors, Cytoplasmic and Nuclear, Leptin, Intercellular Signaling Peptides and Proteins, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
